Blog
RSS FeedPosted by Michael Wonder on 13 Nov 2017
SMC - November 2017 decisions
13 November 2017 - The Scottish Medicines Consortium has today published advice accepting three new medicines for use by NHSScotland. ...
Posted by Michael Wonder on 13 Nov 2017
Medibank 'disappointed' that the ACCC is appealing Federal Court decision says CEO Craig Drummond
13 November 2017 - Medibank chief executive Craig Drummond says the private health insurer is "disappointed" that the competition watchdog ...
Posted by Michael Wonder on 12 Nov 2017
NHS England, Roche come to agreement on Perjeta
10 November 2017 - NHS England and Roche have agreed a confidential commercial agreement on the price of Perjeta for ...
Posted by Michael Wonder on 12 Nov 2017
Evaluation of patient and public involvement initiatives in health technology assessment: a survey of international agencies
10 November 2017 - Although there is increased awareness of patient and public involvement among health technology assessment organisations, evaluations of ...
Posted by Michael Wonder on 12 Nov 2017
Public Summary Documents - PBAC July 2017 meeting
10 November 2017 - The public summary documents (first time rejections and deferrals) from the July 2017 PBAC meeting are ...
Posted by Michael Wonder on 10 Nov 2017
Agenda for 9 November TC meeting
7 November 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 10 Nov 2017
NICE recommends Mavenclad (cladribine tablets) for highly active multiple sclerosis
9 November 2017 - First multiple sclerosis therapy to achieve positive NICE recommendation in the shortest possible timeframe. ...
Posted by Michael Wonder on 09 Nov 2017
NICE brings on board Sigma to boost med tech uptake
9 November 2017 - NICE is linking with user experience agency Sigma to develop a new system to improve the ...
Posted by Michael Wonder on 09 Nov 2017
NICE turns down Bayer’s Stivarga for liver cancer
8 November 2017 - Bayer’s Stivarga is not being recommended by NHS treatment cost regulators for certain patients with advanced ...
Posted by Michael Wonder on 09 Nov 2017
'Mind the gap' revisited
6 November 2017 - John Zalcberg and I note with interest the article by Evans et al recently published in ...
Posted by Michael Wonder on 09 Nov 2017
Decision to fund zoster vaccine
9 November 2017 - PHARMAC is pleased to announce the approval of an agreement with Merck Sharpe & Dohme to ...
Posted by Michael Wonder on 08 Nov 2017
Proposal to list methylnaltrexone bromide
8 November 2017 - PHARMAC is seeking feedback on a proposal to list methylnaltrexone bromide (Relistor) 12 mg/0.6 mL injection in ...
Posted by Michael Wonder on 07 Nov 2017
PBS drug price reforms come up 840 million dollars short
6 November 2017 - A much-lauded savings measure for the Pharmaceutical Benefits Scheme came up $840 million short last year ...
Posted by Michael Wonder on 05 Nov 2017
NHS patients should have a choice of drug for wet age-related macular degeneration, despite pressure from pharma
1 November 2017 - Commissioners have to pay more than lip service to the obligation on us to find cost ...
Posted by Michael Wonder on 05 Nov 2017
New hope for families affected by spinal muscular atrophy, with TGA approving drug
4 November 2017 - A drug that can extend the life of children and adults with spinal muscular atrophy (SMA) ...